A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

[1]  W. Willett,et al.  Aspirin use in relation to risk of prostate cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  H. Jick,et al.  Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.

[3]  Michael J Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[4]  R. Shore,et al.  Aspirin and epithelial ovarian cancer. , 2001, Preventive medicine.

[5]  M. Cotterchio,et al.  Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  S. Khuder,et al.  Breast cancer and NSAID use: a meta-analysis , 2001, British Journal of Cancer.

[7]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[8]  J. Olsen,et al.  Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin , 2000, American Journal of Gastroenterology.

[9]  J. Olsen,et al.  Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. , 2000 .

[10]  R. Lancashire,et al.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.

[11]  J. Mclaughlin,et al.  Epidemiologic aspects of renal cell cancer. , 2000, Seminars in oncology.

[12]  M. Yu,et al.  Non-steroidal anti-inflammatory drugs and bladder cancer prevention , 2000, British Journal of Cancer.

[13]  K. Juel,et al.  The Danish registers of causes of death. , 1999, Danish medical bulletin.

[14]  A. Norrish,et al.  Non‐steroidal anti‐inflammatory drugs and prostate cancer progression , 1998, International journal of cancer.

[15]  S. Shapiro,et al.  Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma , 1998, Cancer.

[16]  J. Manson,et al.  Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study , 1998, Annals of Internal Medicine.

[17]  J. Olsen,et al.  Cancer Risk of Patients Discharged with Acute Myocardial Infarct , 1998, Epidemiology.

[18]  M. Gammon,et al.  Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  H. Storm,et al.  The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.

[20]  H. Sørensen,et al.  The Danish prescription registries. , 1997, Danish medical bulletin.

[21]  M. Schuler.  Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.

[22]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[23]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[24]  John C. Bailar,et al.  202. Note: Significance Factors for the Ratio of a Poisson Variable to Its Expectation , 1964 .

[25]  C. Bührle,et al.  Renin-producing renal cell carcinomas—clinical and experimental investigations on a special form of renal hypertension , 2004, Urological Research.

[26]  S. Shapiro,et al.  Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  D. Capellà.  Descriptive tools and analysis. , 1993, WHO regional publications. European series.